LSA
ASND icon

Leonteq Securities AG’s Ascendis Pharma A/S ASND Stock Holding History

Leonteq Securities AG’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-855
Closed -$196K – 1280
2026
Q1 		$196K Buy
855
+686
+406% +$154K 0.01% 606
2025
Q4 		$36K Buy
169
+161
+2,013% +$33.3K ﹤0.01% 1005
2025
Q3 		$1.59K Hold
8
– – ﹤0.01% 1231
2025
Q2 		$1.38K Sell
8
-30
-79% -$4.89K ﹤0.01% 1190
2025
Q1 		$5.86K Sell
38
-6,900
-99% -$986K ﹤0.01% 1089
2024
Q4 		$955K Buy
6,938
+6,829
+6,265% +$898K 0.06% 253
2024
Q3 		$16.3K Sell
109
-154
-59% -$20.8K ﹤0.01% 936
2024
Q2 		$35.9K Buy
263
+185
+237% +$25.2K ﹤0.01% 826
2024
Q1 		$11.8K Sell
78
-167
-68% -$23.8K ﹤0.01% 992
2023
Q4 		$30.9K Buy
245
+197
+410% +$19.6K ﹤0.01% 869
2023
Q3 		$4.5K Buy
+48
New +$4.49K ﹤0.01% 1076
2022
Q4 		– Sell
-600
Closed -$62K – 1294
2022
Q3 		$62K Buy
600
+100
+20% +$9.48K ﹤0.01% 755
2022
Q2 		$46.5K Buy
500
+150
+43% +$14.1K ﹤0.01% 843
2022
Q1 		$41.1K Buy
350
+230
+192% +$26.6K ﹤0.01% 898
2021
Q4 		$16.1K Buy
+120
New +$17.9K ﹤0.01% 1091
2021
Q3 		– Sell
-211
Closed -$27.8K – 1132
2021
Q2 		$27.8K Hold
211
– – ﹤0.01% 911
2021
Q1 		$27.2K Buy
+211
New +$32.1K ﹤0.01% 848

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Leonteq Securities AG's ASND Position: Q2 2026 in Review

Leonteq Securities AG sold out of Ascendis Pharma A/S (ASND) in Q2 2026, closing a stake of 855 shares — an estimated $196K sold.

Leonteq Securities AG first reported a position in ASND in Q1 2021 and held it in 17 quarters. The position peaked at $955K in Q4 2024. 310 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Leonteq Securities AG reported no remaining Ascendis Pharma A/S position as of Q2 2026 after selling out during the quarter.
  • Leonteq Securities AG sold 855 Ascendis Pharma A/S shares in Q2 2026, an estimated $196K.
  • Leonteq Securities AG first reported a position in Ascendis Pharma A/S in Q1 2021 and held it in 17 quarters.
  • Leonteq Securities AG's Ascendis Pharma A/S position peaked at $955K in Q4 2024.
  • 310 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.